Natural history of cognitive decline in the old old

Neurology

Volumn 60, Issue 9, 2003, Pages 1489-1494

  Howieson, Diane B ^a,b   Camicioli, R ^d   Quinn, J ^a,c   Silbert, L C ^a,c   Care, B ^a   Moore, M M ^a   Dame, A ^a   Sexton, G ^b   Kaye, J A ^a,c  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^c PORTLAND VA MEDICAL CENTER   (United States)

^d UNIVERSITY OF ALBERTA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN E4;

AGED; AGING; ALZHEIMER DISEASE; ARTICLE; COGNITIVE DEFECT; DEMENTIA; FEMALE; GENOTYPE; HISTORY; HUMAN; MALE; MINI MENTAL STATE EXAMINATION; NORMAL HUMAN; PRIORITY JOURNAL; RISK FACTOR;

EID: 0038220942     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/01.WNL.0000063317.44167.5C     Document Type: Article

References (48)

1. Kral VA. Senescent forgetfulness, benign and malignant. Can Med Assoc J 1962;86:252-260.
2. Albert SM, Talbert MH, Dienstag A, Pelton G, Devanand EE. The impact of mild cognitive impairment on functional abilities in the elderly. Curr Psychiatry Rep 2002;4:64-68.
3. Morris JC, Storandt M, Miller JP, et al. Mild cognitive impairment represents early-stage Alzheimer disease. Arch Neurol 2001;58:397-405.
4. Howieson D, Holm L, Kaye J, et al. Neurologic function in the optimally healthy oldest old: neuropsychologic evaluation. Neurology 1993;43: 1882-1886.
5. Kaye J, Oken B, Howieson D, et al. Neurologic evaluation of the optimally healthy oldest old. Arch Neurol 1994;51:1205-1211.
6. Folstein M, Folstein S, McHugh P. "Mini-mental state." A practical method of grading the cognitive status of patients for clinicians. J Psychiatr Res 1975;12:189-198.
7. Hughes C, Berg L, Danizger W, Cohen L, Martin R. A new clinical scale for the staging of dementia. Brit J Psychiatry 1982;140:566-572.
8. Morris JC. The Clinical Dementia Rating (CDR): current version and scoring rules. Neurology 1993;43:2412-2414.
9. Kiernan R, Meuller J, Langston J, Van Dyke C. The Neurobehavioral Cognitive Status Examination: a brief but differentiated approach to cognitive assessment. Ann Intern Med 1987;107:734-739.
10. Alexopoulos GS, Abrams RC, Young RC, Shamoian CA. Cornell Scale for depression in dementia. Biol Psychiatry 1988;23:271-284.
11. Yesavage JA, Brink TL, Rose TL, Lum O. Development and validation of a geriatric depression screening scale: a preliminary report. J Psychiatr Res 1983;17:37-49.
12. Howieson DB, Dame A, Camicioli R, Sexton G, Payami H, Kaye JA. Cognitive markers preceding Alzheimer's dementia in the healthy oldest old. J Am Geriatr Soc 1997;45:584-589.
13. Hollingshead AB. Two-factor index of social position. New Haven, CT: Hollingshead AB, 1957.
14. Johansson B, Zarit SH. Early cognitive markers of the incidence of dementia and mortality: a longitudinal population-based study of the oldest old. Int J Geriatr Psychiatry 1997;12:53-59.
15. Kaye J, Swihart T, Howieson D, et al. Volume loss of the hippocampus and temporal lobe in healthy elderly persons destined to develop dementia. Neurology 1997;48:1297-1304.
16. Marquis S, Moore MM, Howieson DB, Sexton G, Kaye JA, Camicioli R. Independent predictors of cognitive decline in healthy elderly persons. Arch Neurol 2002;59:601-606.
17. Mueller EA, Moore MM, Kerr DC, et al. Brain volume preserved in healthy elderly through the eleventh decade. Neurology 1998;51:1555-1562.
18. Payami H, Grimslid H, Oken B, et al. A prospective study of cognitive health in the elderly (Oregon Brain Aging Study): effects of family history and apolipoprotein E genotype. Am J Hum Genet 1997;60:948-956.
19. McKahnn G, Drachman D, Folstein M. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA work group under the auspices of the Department of Health and Human Services Task Force on Alzheimer's disease. Neurology 1984;34:939-944.
20. Kaplan EF, Goodglass H, Weintraub S, The Boston Naming Test. 2nd ed. Philadelphia: Lea & Febiger, 1983.
21. Morris JC, Heyman A, Mohs RC, et al. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD), part I: clinical and neuropsychological assessment of Alzheimer's disease. Neurology 1989;39: 1159-1165.
22. Wechsler D. Manual for the Wechsler Adult Intelligence Scale-Revised. New York: Psychological Corporation, 1981.
23. Wechsler D. Wechsler Memory Scale-Revised. New York: Psychological Corporation, 1987.
24. Wechsler D. Wechsler Memory Scale - third edition manual. San Antonio, TX: The Psychological Corporation, 1997.
25. Petersen RC, Smith GE, Waring SC, Ivnik RJ, Tangalos EG, Kokmen E. Mild cognitive impairment: clinical characterization and outcome. Arch Neurol 1999;56:303-308.
26. Christensen H, Henerson AS, Korten AE, Jorm AF, Jacomb PA, Mackinnon AJ. ICD-10 mild cognitive disorder: its outcome three years later. Int J Geriatr Psychiatry 1997;12:581-586.
27. Celsis P, Agniel A, Cardebat D, Demonet JF, Ousset PJ, Puel M. Age related cognitive decline: a clinical entity? A longitudinal study of cerebral blood flow and memory performance. J Neurol Neurosurg Psychiatry 1997;62:601-608.
28. Small SA, Stern Y, Tang M, Mayeux R. Selective decline in memory function among healthy elderly. Neurology 1999;52:1392-1396.
29. Goldman WP, Price JL, Storandt M, et al. Absence of cognitive impairment or decline in preclinical Alzheimer's disease. Neurology 2001;56: 361-367.
30. Katzman R, Kawas C. Risk factors for Alzheimer's disease. Neurosci News 1998;1:27-34.
31. Albert MS, Moss MB, Tanzi R, Jones K. Preclinical prediction of AD using neuropsychological tests. J Int Neuropsychol Soc 2001;7:631-639.
32. Bowen J, Teri L, Kukull W, et al. Progression to dementia in patients with isolated memory loss. Lancet 1997;349:763-765.
33. Cooper B, Bickel H, Schaufele M. Early development and progression of dementing illness in the elderly: a general praxis based study. Psychol Med 1996;26:411-419.
34. Ritchie K, Artero S, Touchon J. Classification criteria for mild cognitive impairment: a population-based validation study. Neurology 2001;56: 37-42.
35. Wolf H, Grunwald M, Ecke GM, et al. The prognosis of mild cognitive impairment in the elderly. J Neurol Transm Suppl 1998;54:31-50.
36. Haxby JV, Raffaele K, Gillette J, Schapiro MB, Rapoport SI. Individual trajectories of cognitive decline in patients with dementia of the Alzheimer type. J Clin Exp Neuropsychol 1992;14:575-592.
37. Piccini C, Bracco L, Falcini M, Pracucci G, Amaducci L. Natural history of Alzheimer's disease: prognostic value of plateaux. J Neurol Sci 1995; 131:177-182.
38. Rubin EH, Storandt M, Miller JP, et al. A prospective study of cognitive function and onset of dementia in cognitively healthy elders. Arch Neurol 1998;55:395-401.
39. Katzman R, Aronson M, Fuld P, et al. Development of dementing illnesses in an 80-year-old volunteer cohort. Ann Neurol 1989;25:317-324.
40. Neuropathology Group. Pathological correlates of late-onset dementia in a multicentre, community-based population in England and Wales. Neuropathology Group of the Medical Research Council Cognitive Function and Ageing Study (MRC CFAS). Lancet 2001;357:169-175.
41. Riley KP, Snowdon DA, Saunders AM, Roses AD, Mortimer JA, Nanayakkara N. Cognitive function and apolipoprotein E in very old adults: findings from the Nun Study. J Gerontol B Pschol Sci Soc Sci 2000;55: S69-S75.
42. Snowdon DA. Aging and Alzheimer's disease: lessons from the Nun Study. Gerontologist 1997;37:150-156.
43. Saunders AM. Apolipoprotein E and Alzheimer disease: an update on genetic and functional analyses. J Neuropathol Exp Neurol 2000;59: 751-758.
44. Kardaun JW, White L, Resnick HE, et al. Genotypes and phenotypes for apolipoprotein E and Alzheimer disease in the Honolulu-Asia aging study. Clin Chem 2000;46:1548-1554.
45. Farrer LA, Cupples LA, Haines JL, et al. Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. APOE and Alzheimer Disease Meta Analysis Consortium. JAMA 1997;278:1349-1356.
46. Oyama F, Shimada H, Oyama R, Ihara Y. Apolipoprotein E genotype, Alzheimer's pathologies and related gene expression in the aged population. Brain Res Mol Brain Res 1995;29:92-98.
47. Fagan AM, Watson M, Parsadanian M, Bales KR, Paul SM, Holtzman DM. Human and murine apoE markedly alters Abeta metabolism before and after plaque formation in a mouse model of A]zheimer's disease. Neurobiol Dis 2002;9:305-318.
48. Stern Y. What is cognitive reserve? Theory and research application of the reserve concept. J Int Neuropsychol Soc 2002;8:448-460.